References

1. Escaned J, Colmenárez H, Ferrer MC, Gutiérrez M, Jiménez-Quevedo P, Hernández R, Alfonso F, Bañuelos C, Deisla LP, Zamorano JL, Macaya C. Diastolic dysfunction in diabetic patients assessed with Doppler echocardiography: relationship with coronary atherosclerotic burden and microcirculatory impairment. Rev Esp Cardiol. 2009 Dec;62(12):1395-403. doi: 10.1016/s1885-5857(09)73534-0.
2. Ernande L, Audureau E, Jellis CL, Bergerot C, Henegar C, Sawaki D, Czibik G, Volpi C, Canoui-Poitrine F, Thibault H, Ternacle J, Moulin P, Marwick TH, Derumeaux G. Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus. J Am Coll Cardiol. 2017 Oct 3;70(14):1704-1716. doi: 10.1016/j.jacc.2017.07.792.
3. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004;27:1879–84. doi: 10.2337/diacare.27.8.1879.
4. Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol. 2001;38:421–8. doi: 10.1016/S0735-1097(01)01408-5.
5. Jaarsma T, Van der Wal MH, Lesman-Leegte I. for the COACH Study Group et al.Effect of moderate or intensive disease management program on outcome in patients with heart failure. The Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure (COACH) Arch Intern Med. 2008;168:316–24. doi: 10.1001/archinternmed.2007.83.
6. Grigorescu ED, Lacatusu CM, Floria M, Mihai BM, Cretu I, Sorodoc L. Left Ventricular Diastolic Dysfunction in Type 2 Diabetes-Progress and Perspectives. Diagnostics (Basel). 2019;9(3):121. Published 2019 Sep 17. doi:10.3390/diagnostics9030121.
7. Jørgensen PG, Jensen MT, Mogelvang R, von Scholten BJ, Bech J, Fritz-Hansen T, Galatius S, Biering-Sørensen T, Andersen HU, VilsbøllT, Rossing P, Jensen JS. Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics. Diab Vasc Dis Res. 2016 Sep;13(5):321-30. doi: 10.1177/1479164116645583.
8. Ashour K (2018) Early Detection of Diastolic Dysfunction in Diabetic Patients (Single Center Cross Sectional Study). J Heart Cardiovasc Res. Vol.2 No.1:3.
9. Saunders J, Mathewkutty S, Drazner MH, McGuire DK. Cardiomyopathy in type 2 diabetes: update on pathophysiological mechanisms. Herz. 2008;33:184–90. doi: 10.1007/s00059-008-3115-3.
10. Romano S, Di Mauro M, Fratini S, Guarracini L  Guarracini F, Poccia G, Penco M. Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides. Cardiovasc Diabetol. 2010; 9: 89. doi: 10.1186/1475-2840-9-89.
11. Celentano A, Vaccaro O, Tammaro P, Galderisi M, Crivaro M, et al. (1995) Early abnormalities of cardiac function in non-insulindependent diabetes mellitus and impaired glucose tolerance. Am J Cardiol. 1995 Dec 1;76(16):1173-6. doi: 10.1016/s0002-9149(99)80330-0.
12. Ponikowski P, Voors AA, Anker SD (2016) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18: 891-975.
13. Kristensen SL, Mogensen UM, Jhund PS, Petrie MC, Preiss D, Win S, Køber L, McKelvie RS, Zile MR, Anand IS, Komajda M, Gottdiener JS, Carson PE, McMurray JJ. Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes according to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction). Circulation. 2017 Feb 21;135(8):724-735. doi: 10.1161/CIRCULATIONAHA.116.024593.
14. Jensen MT, Sogaard P, Gustafsson I, Bech J, Hansen TF, Almdal T, Theilade S, Biering-Sørensen T, Jørgensen PG, Galatius S, Andersen HU, Rossing P. Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: the Thousand & 1 Study. Diabetologia. 2019 Dec;62(12):2354-2364. doi: 10.1007/s00125-019-05009-2.
15. Kadappu KK, Boyd A, Eshoo S, Haluska B, Yeo AE, Marwick TH, Thomas L. Changes in left atrial volume in diabetes mellitus: more than diastolic dysfunction? Eur Heart J Cardiovasc Imaging. 2012 Dec;13(12):1016-23. doi: 10.1093/ehjci/jes084.
16. Fang ZY, Yuda S, Anderson V, Short L, Case C, Marwick TH. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol. 2003 Feb 19;41(4):611-7.
17. Ringle Α, Dornhorst Α, Rehman ΜΒ, Ruisanchez C, Nihoyannopoulos P. Evolution of subclinical myocardial dysfunction detected by two-dimensional and three-dimensional speckle tracking in asymptomatic type 1 diabetic patients: a long term follow-up study. Echo Res Pract. 2017 Dec; 4(4): 73–81. doi: 10.1530/ERP-17-0052.
18. Conte L, Fabiani I, Barletta V, Bianchi C, Ciccarone AM, Cucco C, De Filippi M, Miccoli R, Del Prato S, Palombo C, Di Bello Early Detection of Left Ventricular Dysfunction in Diabetes Mellitus Patients with Normal Ejection Fraction, Stratified by BMI: A Preliminary Speckle Tracking Echocardiography Study. J Cardiovasc Echogr. 2013 Jul-Sep; 23(3): 73–80. doi: 10.4103/2211-4122.123953.
19. Flores-Ramírez R, Azpiri-López JR, González-González JG, Ordaz-Farías A, González-Carrillo LE, Carrizales-Sepúlveda EF, Vera-Pineda R. Global longitudinal strain as a biomarker in diabetic cardiomyopathy. A comparative study with Gal-3 in patients with preserved ejection fraction. Arch Cardiol Mex. 2017 Oct - Dec;87(4):278-285. doi: 10.1016/j.acmx.2016.06.002.
20. Jensen MT, Sogaard P, Andersen HU, Bech J, Fritz Hansen T, Biering-Sørensen T, Jørgensen PG, Galatius S, Madsen JK, Rossing P, Jensen JS. Global longitudinal strain is not impaired in type 1 diabetes patients without albuminuria: the Thousand & 1 study. JACC Cardiovasc Imaging. 2015 Apr;8(4):400-410. doi: 10.1016/j.jcmg.2014.12.020.
21. Zairi I, Mzoughi K, Kamoun S, Moussa FB, Rezgallah R, Maatoug J, Mazigh S, Kraiem S. Impairment of left and right ventricular longitudinal strain in asymptomatic children with type 1 diabetes. Indian Heart J. 2019 May-Jun; 71(3): 249–255. doi: 10.1016/j.ihj.2019.04.008.
22. Mohamed M. Assessment of left ventricular functions by strain and strain rate echocardiography in asymptomatic type II diabetic patients. Al-Azhar Assiut Med J 2019; 17 (2):119-131. doi: 10.4103/AZMJ.AZMJ_16_18.
23. Liu JH, Chen Y, Yuen M, Zhen Z, Chan CW, Lam KS, Tse HF, Yiu KH. Incremental prognostic value of global longitudinal strain in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2016 Feb 3;15:22. doi: 10.1186/s12933-016-0333-5.
24. Leung M, Wong VW, Hudson M, Leung DY. Impact of Improved Glycemic Control on Cardiac Function in Type 2 Diabetes Mellitus. Circ Cardiovasc Imaging. 2016 Mar;9(3):e003643. doi: 10.1161/CIRCIMAGING.115.003643.
25. Hensel KO, Grimmer F, Roskopf M, Jenke AC, Wirth S, Heusch A. Subclinical Alterations of Cardiac Mechanics Present Early in the Course of Pediatric Type 1 Diabetes Mellitus: A Prospective Blinded Speckle Tracking Stress Echocardiography Study. J Diabetes Res. 2016;2016:2583747. doi: 10.1155/2016/2583747.
26. Enomoto M, Ishizu T, Seo Y, Yamamoto M, Suzuki H, Shimano H, Kawakami Y, Aonuma K. Subendocardial Systolic Dysfunction in Asymptomatic Normotensive Diabetic Patients. Circ J. 2015;79(8):1749-55. doi: 10.1253/circj.CJ-15-0012.
27. Iso T, Takahashi K, Yazaki K, Ifuku M, Nii M, Fukae T, Yazawa R, Ishikawa A, Haruna H, Takubo N, Kurita M, Ikeda F, Watada H, Shimizu T. In-Depth Insight Into the Mechanisms of Cardiac Dysfunction in Patients With Type 1 Diabetes Mellitus Using Layer-Specific Strain Analysis. Circ J. 2019 May 24;83(6):1330-1337. doi: 10.1253/circj.CJ-18-1245.
28. Georgievska-Ismail L, Zafirovska P, Hristovski Z. Evaluation of the role of left atrial strain using two-dimensional speckle tracking echocardiography in patients with diabetes mellitus and heart failure with preserved left ventricular ejection fraction. Diab Vasc Dis Res. 2016 Nov;13(6):384-394. doi: 10.1177/1479164116655558.
29. Mondillo S, Cameli M, Caputo ML, Lisi M, Palmerini E, Padeletti M, Ballo P. Early detection of left atrial strain abnormalities by speckle-tracking in hypertensive and diabetic patients with normal left atrial size. J Am Soc Echocardiogr. 2011 Aug;24(8):898-908. doi: 10.1016/j.echo.2011.04.014.
30. Bogdanović J, Ašanin M, Krljanac G, Lalić N, Jotić A, Stanković S, Rajković N, Stošić L, Rasulić I, Milin J, Popović D, Bogdanović L, Lalić K. Impact of acute hyperglycemia on layer-specific left ventricular strain in asymptomatic diabetic patients: an analysis based on two-dimensional speckle tracking echocardiography. Cardiovasc Diabetol. 2019 Jun 3;18(1):68. doi: 10.1186/s12933-019-0876-3.
31. Ikonomidis I, Pavlidis G, Lambadiari V, Kousathana F, Varoudi M, Spanoudi F, Maratou E, Parissis J, Triantafyllidi H, Dimitriadis G, Lekakis J. Early detection of left ventricular dysfunction in first-degree relatives of diabetic patients by myocardial deformation imaging: The role of endothelial glycocalyx damage. Int J Cardiol. 2017 Apr 15;233:105-112. doi: 10.1016/j.ijcard.2017.01.056.
32. Ikonomidis, I., Pavlidis, G., Thymis, J., Birba, D., Kalogeris, A., Kousathana, F., Kountouri, A., Balampanis, K., Parissis, J., Andreadou, I., Katogiannis, K., Dimitriadis, G., Bamias, A., Iliodromitis, E., & Lambadiari, V. (2020). Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12-Month Treatment. Journal of the American Heart Association, 9(9), e015716. https://doi.org/10.1161/JAHA.119.015716.
33. Lambadiari, V., Pavlidis, G., Kousathana, F., Maratou, E., Georgiou, D., Andreadou, I., Kountouri, A., Varoudi, M., Balampanis, K., Parissis, J., Triantafyllidi, H., Katogiannis, K., Birba, D., Lekakis, J., Dimitriadis, G., & Ikonomidis, I. (2019). Effects of Different Antidiabetic Medications on Endothelial Glycocalyx, Myocardial Function, and Vascular Function in Type 2 Diabetic Patients: One Year Follow-Up Study. Journal of clinical medicine, 8(7), 983. https://doi.org/10.3390/jcm8070983.
34. Sharma R, Pellerin D. Stress echocardiogaphy: a useful test for assessing cardiac risk in diabetes. Vasc Health Risk Manag. 2009;5(1):1-7.
35. Bhattacharyya S, Kamperidis V, Chahal N, Shah BN, Roussin I, Li W, Khattar R, Senior R. Clinical and prognostic value of stress echocardiography appropriateness criteria for evaluation of coronary artery disease in a tertiary referral center. Heart. 2014; 100: 370-374.
36. Aggeli C, Felekos I, Angelis A, Toutouzas K, Tousoulis D. Dobutamine stress echo in diabetics: Changes in prognosis according to appropriateness criteria indication. Int J Cardiol. 2016 Jul 1;214:207-8. doi: 10.1016/j.ijcard.2016.03.179.
37. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425.
38. Chaowalit N, Arruda AL, McCully RB, Bailey KR, Pellikka PA. Dobutamine stress echocardiography in patients with diabetes mellitus: enhanced prognostic prediction using a simple risk score. J Am Coll Cardiol. 2006 Mar 7;47(5):1029-36. doi: 10.1016/j.jacc.2005.10.048.
39. D'Andrea A, Severino S, Caso P, De Simone L, Liccardo B, Forni A, Pascotto M, Di Salvo G, Scherillo M, Mininni N, Calabrò R. Prognostic value of pharmacological stress echocardiography in diabetic patients. Eur J Echocardiogr. 2003 Sep;4(3):202-8. doi:10.1016/S1525-2167(02)00165-8.
40. Bigi R, Desideri A, Cortigiani L, Bax JJ, Celegon L, Fiorentini C. Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. Diabetes Care. 2001 Sep;24(9):1596-601. doi: 10.2337/diacare.24.9.1596.
41. Cortigiani L, Borelli L, Raciti M, Bovenzi F, Picano E, Molinaro S, Sicari R. Prediction of mortality by stress echocardiography in 2835 diabetic and 11305 nondiabetic patients. Circ Cardiovasc Imaging. 2015 May;8(5). pii: e002757. doi: 10.1161/CIRCIMAGING.114.002757.
42. Sicari R, Cortigiani L. The clinical use of stress echocardiography in ischemic heart disease. Cardiovasc Ultrasound. 2017 Mar 21;15(1):7. doi: 10.1186/s12947-017-0099-2.
43. Bates JR, Sawada SG, Segar DS, Spaedy AJ, Petrovic O, Fineberg NS, Feigenbaum H, Ryan T. Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation. Am J Cardiol. 1996 Jan 15;77(2):175-9. doi: 10.1016/s0002-9149(96)90591-3.
44. Poldermans D, Arnese M, Fioretti PM, et al. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol. 1995;26:648–53.
45. Cortigiani L, Gherardi S, Faggioni M, Bovenzi F, Picano E, Petersen C, Molinaro S, Sicari R. Dual-Imaging Stress Echocardiography for Prognostic Assessment of High-Risk Asymptomatic Patients with Diabetes Mellitus. J Am Soc Echocardiogr. 2017 Feb;30(2):149-158. doi: 10.1016/j.echo.2016.10.003.
46. van der Sijde JN, Boiten HJ, Sozzi FB, Elhendy A, van Domburg RT, Schinkel AF. Long-term prognostic value of dobutamine stress echocardiography in diabetic patients with limited exercise capability: a 13-year follow-up study. Diabetes Care. 2012;35:634–9.
47. Philouze C, Obert P, Nottin S, Benamor A, Barthez O, Aboukhoudir F. Dobutamine Stress Echocardiography Unmasks Early Left Ventricular Dysfunction in Asymptomatic Patients with Uncomplicated Type 2 Diabetes: A Comprehensive Two-Dimensional Speckle-Tracking Imaging Study. J Am Soc Echocardiogr. 2018 May;31(5):587-597. doi: 10.1016/j.echo.2017.12.006.
48. Kawata T, Daimon M, Hasegawa R, Toyoda T, Sekine T, Himi T, Uchida D, Miyazaki S, Hirose K, Ichikawa R, Maruyama M, Suzuki H, Daida H. Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long- term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease. Cardiovasc Diabetol. 2013 Aug 27;12:121. doi: 10.1186/1475-2840-12- 21.
49. Nemes A, Forster T, Geleijnse ML, Kutyifa V, Neu K, Soliman OI, Ten Cate FJ, Csanády M. The additional prognostic power of diabetes mellitus on coronary flow reserve in patients with suspected coronary artery disease. Diabetes Res Clin Pract. 2007 Oct;78(1):126-31. doi: 10.1016/j.diabres.2007.03.002.
50. Atar AI, Altuner TK, Bozbas H, Korkmaz ME. Coronary flow reserve in patients with diabetes mellitus and prediabetes. Echocardiography. 2012 Jul;29(6):634-40. doi: 10.1111/j.1540-8175.2012.01668.x.
51. Ikonomidis I, Lambadiari V, Pavlidis G, Koukoulis C, Kousathana F, Varoudi M, Spanoudi F, Maratou E, Parissis J, Triantafyllidi H, Paraskevaidis I, Dimitriadis G, Lekakis J. Insulin resistance and acute glucose changes determine arterial elastic properties and coronary flow reserve in dysglycaemic and first-degree relatives of diabetic patients. Atherosclerosis. 2015 Aug;241(2):455-62. doi: 10.1016/j.atherosclerosis.2015.06.006.
52. Akasaka T, Yoshida K, Hozumi T, Takagi T, Kaji S, Kawamoto T, Morioka S, Yoshikawa J. Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus. J Am Coll Cardiol. 1997 Oct;30(4):935-41. doi: 10.1016/s0735-1097(97)00242-8.
53. Strauer BE, Motz W, Vogt M, Schwartzkopff B. Evidence for reduced coronary flow reserve in patients with insulin-dependent diabetes. A possible cause for diabetic heart disease in man. Exp Clin Endocrinol Diabetes. 1997;105(1):15-20. doi: 10.1055/s-0029-1211722.
54. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Woo-Soo S, Nishikawa J, Sasaki Y, Omata M. Hyperglycemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM. Diabetes. 1998 Jan;47(1):119-24. doi: 10.2337/diab.47.1.119.